Metraipolis › archive › dc_9b91083f2552
Overcoming resistance to anti-PD-1/PD-L1 therapy in cancer — Europe PMC PMID:42267193
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42267193
- DOI
- 10.20517/cdr.2026.12
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T06:41:28.113Z
- SHA-256 of the archived text
336b535b508fde7a1d2adba49750ff42135f38cfb9097043eca1e7bf2e6193d2- Stable URL of this page
https://metraipolis.com/documento/dc_9b91083f2552
How to cite
Overcoming resistance to anti-PD-1/PD-L1 therapy in cancer — Europe PMC PMID:42267193 — Europe PMC (en), https://europepmc.org/article/MED/42267193 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9b91083f2552 (Metraipolis archive dc_9b91083f2552, sha256 336b535b508fde7a1d2adba49750ff42135f38cfb9097043eca1e7bf2e6193d2)
BibTeX
@misc{dc9b91083f2552,
title = {Overcoming resistance to anti-PD-1/PD-L1 therapy in cancer — Europe PMC PMID:42267193},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42267193},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9b91083f2552; sha256 336b535b508fde7a1d2adba49750ff42135f38cfb9097043eca1e7bf2e6193d2},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42267193. Agents can read the archived copy with the MCP tool read_document.